Coq and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Coq (coenzyme q - 10), especially for people who are male, 60+ old, also take Norco, and have Breast cancer.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Coq. It is created by eHealthMe based on reports of 9,924 people who have side effects when taking Coq from the FDA, and is updated regularly.

What is Coq?

Coq has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 11,465 Coq users. Check the latest studies of Coq.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,956 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 13, 2026

9,924 people reported to have side effects when taking Coq.
Among them, 30 people (0.3%) have Hyperkalemia.

Among these 30 people:

What is the gender of people who have Hyperkalemia when taking Coq? *

female: 43.33 %
male: 56.67 %

What is the age of people who have Hyperkalemia when taking Coq? *

What are other drugs people take besides Coq? *

What are other side effects people have besides Hyperkalemia? *

Pain: 10 people, 33.33%
Diarrhea: 9 people, 30.00%
Acute Kidney Failure: 8 people, 26.67%
Oedema Peripheral (superficial swelling): 8 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 8 people, 26.67%
Fall: 7 people, 23.33%
Nausea (feeling of having an urge to vomit): 7 people, 23.33%
Fatigue (feeling of tiredness): 7 people, 23.33%
High Blood Pressure: 6 people, 20.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 20.00%

What are the existing conditions these people have? *

Bone Cancer Metastatic: 5 people, 16.67%
Metastases To Bone (cancer spreads to bone): 5 people, 16.67%
Breast Cancer: 5 people, 16.67%
Neuralgia (pain in one or more nerves): 4 people, 13.33%
Gout (uric acid crystals building up in the body): 4 people, 13.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 13.33%
Cardiac Disorder: 4 people, 13.33%
Urination - Painful: 4 people, 13.33%
Neuropathy Peripheral (surface nerve damage): 4 people, 13.33%
Osteomyelitis (infection of bone): 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Coq and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coq:

Coq (11,465 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Coq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,956 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,936 conditions)

Related publications that referenced our studies

Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Coq) and Coq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.